Parkinson disease: etiology, pathogenesis and future of gene therapy (Q34355457)

1 August 2017

1 reference

title

Parkinson disease: etiology, pathogenesis and future of gene therapy (English)

1 reference

1 August 2017

0 references

1 reference

Shastry BS

1

1 reference

1 August 2017

publication date

1 September 2001

1 reference

1 August 2017

published in

Neuroscience Research

1 reference

1 August 2017

volume

41

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

5-12

1 reference

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

GSTM1 and mEPHX polymorphisms in Parkinson's disease and age of onset

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Dopaminergic Neurons Intrinsic to the Primate Striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

A one-hit model of cell death in inherited neuronal degenerations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

A Drosophila model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

The cellular chamber of doom.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Two novel point mutations of mitochondrial tRNA genes in histologically confirmed Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Molecular genetic analysis of a novelParkin gene in Japanese families with autosomal recessive juvenile parkinsonism: Evidence for variable homozygous deletions in theParkin gene in affected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Point mutations (Thr240Arg and Gln311Stop) [correction of Thr240Arg and Ala311Stop] in the Parkin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Point mutations of mitochondrial genome in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Mitochondrial DNA polymorphism in substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Progress in the clinical and molecular genetics of familial parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Molecular cloning, gene expression, and identification of a splicing variant of the mouse parkin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Exonic deletion mutations of the Parkin gene among sporadic patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Aggresomes, inclusion bodies and protein aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

The ubiquitin pathway in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Association between early-onset Parkinson's disease and mutations in the parkin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Treatment of early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Immunocytochemical characterization of catecholaminergic neurons in the rat striatum following dopamine-depleting lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Biomedicine. Combating Parkinson's disease--step three

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile Parkinsonism in a population from North West Colombia.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Tau is a candidate gene for chromosome 17 frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

1 reference

7 January 2021

Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Association of coffee and caffeine intake with the risk of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

1 reference

7 January 2021

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Mitochondrial oxidative phosphorylation defects in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Dopamine agonists in early therapy for Parkinson disease: promise and problems

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Parkinson disease in twins: an etiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Aggregates in neurodegenerative disease: crowds and power?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Prevalence of homozygous deletions of the parkin gene in a cohort of patients with sporadic and familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

1 reference

7 January 2021

Progression of parkinsonism and loss of cognitive function in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

The engagement of Sec61p in the ER dislocation process

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2801%2900254-1

7 January 2021

10.1016/S0168-0102(01)00254-1

Identifiers

DOI

1 reference

1 August 2017

1 reference